Market Indices
Sector Heatmap
BDSX — Biodesix, Inc. Common Stock
NasdaqBiodesix, Inc. Common Stock
- O
- 27.55
- H
- 28.72
- L
- 26.97
- V
- 124.14K
Chart
About BDSX
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Key Financial Statistics
| Market Cap | $307.04M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.26 - $31.97 |
| 52-Week Avg Volume | 435.8K |
| VWAP | $28.15 |
| Transactions | 3,519 |
| Total Recorded Bars | 1,489 days |